Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical (Q34691408)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical |
scientific article |
Statements
1 reference
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical (English)
1 reference
S K Garg
1 reference
B W Bode
1 reference
J B Buse
1 reference
M Fisher
1 reference
L Merker
1 reference
E Renard
1 reference
D L Russell-Jones
1 reference
C T Hansen
1 reference
A Rana
1 reference
S R Heller
1 reference
BEGIN® Basal-Bolus Type 1 trial investigators
1 reference
1 reference
1 reference
Identifiers
1 reference